title: Therapy of renal anemia with recombinant human erythropoietin in children with end-stage renal disease.
authors.affiliation: Boehringer Mannheim GmbH, Department of Clinical Research, Mannheim, FRG.
authors.forename: P
authors.initials: P
authors.lastname: Scigalla
authors.forename: K E
authors.initials: KE
authors.lastname: Bonzel
authors.forename: M
authors.initials: M
authors.lastname: Bulla
authors.forename: R
authors.initials: R
authors.lastname: Burghard
authors.forename: J
authors.initials: J
authors.lastname: Dippel
authors.forename: J
authors.initials: J
authors.lastname: Geisert
authors.forename: E
authors.initials: E
authors.lastname: Leumann
authors.forename: T
authors.initials: T
authors.lastname: von Lilien
authors.forename: D E
authors.initials: DE
authors.lastname: Müller-Wiefel
authors.forename: G
authors.initials: G
authors.lastname: Offner
mesh_terms: D000293:Adolescent; D000328:Adult; D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D004906:Erythrocyte Count; D004921:Erythropoietin / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005293:Ferritins / Q000378:metabolism; D006128:Growth / Q000187:drug effects; D006400:Hematocrit; D006801:Humans; D006973:Hypertension / Q000139:chemically induced; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications*; D008297:Male; D015337:Multicenter Studies as Topic; D012156:Reticulocytes; D012640:Seizures / Q000139:chemically induced; D013927:Thrombosis / Q000139:chemically induced
chemical_list: D004921:Erythropoietin; D005293:Ferritins